InvestSMART

Emyria Limited (ASX: EMD) - Share Price

- Current share price for EMD : $0.032

Emyria Limited (EMD) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is engaged in delivering and developing new treatments for mental health and selected neurological conditions. The Group's activities are informed by Real-World Data collected with patients across its wholly owned clinical service subsidiaries.

EMD General Information +

ASX Code EMD
Website http://emyria.com
Industry/Sector Pharmaceuticals
Market Cap ($M) 26
EMD Share Price $0.032
Day High $0.032
Day Low $0.030
Last Close $0.032
EMD Share Price Movement - ( No change )
Prices as at 16:40, 20 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Emyria Limited (EMD) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Emyria Limited (EMD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Emyria Limited (EMD) price-sensitive announcements

EMD - Emyria Recruits 31 Therapists to Meet Growing Patient Demand
Emyria Limited announced it has recruited 31 additional therapists to increase treatment c
Emyria Limited (EMD)
19 Nov 2026 | 9:23 AM
EMD - September 2026 Quarterly Activities Report and Appendix 4C
Emyria Limited’s September 2026 Quarterly Activities Report and Appendix 4C reported a str
Emyria Limited (EMD)
29 Oct 2026 | 9:50 AM
EMD - Emyria Successfully Opens First NSW Empax Clinic
Emyria Limited announced that it has successfully opened its first New South Wales Empax c
Emyria Limited (EMD)
29 Sep 2026 | 9:03 AM
EMD - FDA Selects EMD to Present at Psychedelic Medicines Hearing
Emyria Limited announced that it has been selected by the U.S. Food and Drug Administratio
Emyria Limited (EMD)
10 Sep 2026 | 9:35 AM

Emyria Limited (EMD) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Emyria Limited (EMD)
ORDINARY FULLY PAID
Health Care $26 Emyria Recruits 31 Therapists to Meet Growing Patient Demand 19 Nov 2026 9:23AM $0.032 $0.032 fallen by 0%
Emyria Limited (EMD)
ORDINARY FULLY PAID
Health Care $26 Change of Director's Interest Notice x 2 18 Nov 2026 8:42AM $0.034 $0.032 fallen by 5.88%
Emyria Limited (EMD)
ORDINARY FULLY PAID
Health Care $26 Application for quotation of securities - EMD 18 Nov 2026 8:17AM $0.034 $0.032 fallen by 5.88%
Emyria Limited (EMD)
ORDINARY FULLY PAID
Health Care $26 Final Director's Interest Notice - J. Tooke 12 Nov 2026 5:38PM $0.038 $0.032 fallen by 15.79%
Emyria Limited (EMD)
ORDINARY FULLY PAID
Health Care $26 Results of Annual General Meeting 12 Nov 2026 5:34PM $0.038 $0.032 fallen by 15.79%
Emyria Limited (EMD)
ORDINARY FULLY PAID
Health Care $26 2026 Annual General Meeting Presentation 12 Nov 2026 3:33PM $0.038 $0.032 fallen by 15.79%

EMD Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$5.88 -$0.80 14.30% 0.00 0.00 0.00% 0.0%
2025A -$3.15 -$0.70 -44.90% 0.00 0.00 0.00% 0.0%
2024A -$4.56 -$1.30 -28.30% 0.00 0.00 0.00% 0.0%

EMD Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
Clarity Pharmaceuticals Ltd (CU6) $685M 0.4454 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Emyria Limited (EMD) $26M 0.1429 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $2,790M -0.7857 0.2462 0.9655 94.5853 75.8966 38.6140 0.00% 1.59% 1.91%

EMD Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 2.91 0.00
Market 0.27 13.00 1.00 0.72
Sector 1.86 32.70 1.92 2.72

EMD Directors

Name Position Start Date
Dr Michael Winlo Managing Director 8 Nov 2019
Mr Greg Hutchinson Non-Executive Chairman, Non-Executive Director 21 Nov 2023
Dr Karen Smith Non-Executive Director 29 Nov 2021
Dr Mohit Kaushal Non-Executive Director 21 Aug 2023

Emyria Limited (EMD) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
29 Aug 2025 HUTCHINSON, Greg Issued Indirect Shares 7,583,333 $0.024 $181,999.992
29 Aug 2025 WINLO, Michael Issued Direct Shares 208,333 $0.024 $4,999.992
4 Apr 2025 WINLO, Michael Buy Direct Shares 69,378 $0.027 $1,873.206

See all changes in directors' interest & trades for Emyria Limited (EMD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EMD Management

Name Position
Susan Patricia Park Company Secretary

EMD Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Emyria Limited (EMD). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
54,788,694 (8.25%) Stewart James Washer
35,071,429 (7.14%) Gregory Hutchinson

EMD Calendar of Events

Date Event
08 October 2027 Report (Annual)
30 August 2027 Report (Prelim)
25 February 2027 Report (Interim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.